Suppressive Antibiotic Treatment in Prosthetic Joint Infections: A Perspective.

prolonged antibiotic prosthetic joint infection suppressive antibiotic treatment

Journal

Antibiotics (Basel, Switzerland)
ISSN: 2079-6382
Titre abrégé: Antibiotics (Basel)
Pays: Switzerland
ID NLM: 101637404

Informations de publication

Date de publication:
19 Jun 2021
Historique:
received: 24 05 2021
revised: 14 06 2021
accepted: 15 06 2021
entrez: 2 7 2021
pubmed: 3 7 2021
medline: 3 7 2021
Statut: epublish

Résumé

The treatment of prosthetic joint infections (PJIs) is a complex matter in which surgical, microbiological and pharmacological aspects must be integrated and, above all, placed in the context of each patient to make the best decision. Sometimes it is not possible to offer curative treatment of the infection, and in other cases, the probability that the surgery performed will be successful is considered very low. Therefore, indefinite administration of antibiotics with the intention of "suppressing" the course of the infection becomes useful. For decades, we had little information about suppressive antibiotic treatment (SAT). However, due to the longer life expectancy and increase in orthopaedic surgeries, an increasing number of patients with infected joint prostheses experience complex situations in which SAT should be considered as an alternative. In the last 5 years, several studies attempting to answer the many questions that arise on this issue have been published. The aim of this publication is to review the latest published evidence on SAT.

Identifiants

pubmed: 34205424
pii: antibiotics10060743
doi: 10.3390/antibiotics10060743
pmc: PMC8235685
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Références

Clin Infect Dis. 1998 Oct;27(4):711-3
pubmed: 9798021
Int J Antimicrob Agents. 2019 Nov;54(5):668-672
pubmed: 31400471
Int J Infect Dis. 2014 Dec;29:184-9
pubmed: 25447723
J Bone Joint Surg Am. 2015 Aug 5;97(15):1220-32
pubmed: 26246256
Clin Infect Dis. 2006 Feb 15;42(4):471-8
pubmed: 16421790
Nat Med. 2019 Dec;25(12):1822-1832
pubmed: 31806905
J Bone Jt Infect. 2017 Jan 15;2(2):77-83
pubmed: 28529867
J Antimicrob Chemother. 2009 Jun;63(6):1264-71
pubmed: 19336454
Infection. 2018 Feb;46(1):39-47
pubmed: 29052797
J Bone Jt Infect. 2019 Nov 6;4(6):268-276
pubmed: 31966956
Bone Joint J. 2017 Nov;99-B(11):1458-1466
pubmed: 29092984
Clin Microbiol Infect. 2004 Sep;10(9):831-7
pubmed: 15355415
J Arthroplasty. 1988;3(2):109-16
pubmed: 3397740
Clin Microbiol Infect. 2020 Apr;26(4):499-505
pubmed: 31539638
Clin Orthop Relat Res. 2003 Sep;(414):55-60
pubmed: 12966277
Genes (Basel). 2020 Dec 30;12(1):
pubmed: 33396759
Infect Dis Clin North Am. 2015 Mar;29(1):109-22
pubmed: 25677705
J Antimicrob Chemother. 2019 Jul 1;74(7):2060-2064
pubmed: 31220276
Orthopedics. 1991 Aug;14(8):841-4
pubmed: 1923965
J Arthroplasty. 2020 Apr;35(4):1154-1160
pubmed: 31955984
Eur J Orthop Surg Traumatol. 2020 Feb;30(2):313-321
pubmed: 31578679
Arch Orthop Trauma Surg. 2009 Apr;129(4):449-53
pubmed: 18379800
Infection. 2003 Mar;31(2):99-108
pubmed: 12682815
Clin Microbiol Infect. 2011 Nov;17(11):1632-7
pubmed: 20678178
Int J Antimicrob Agents. 2017 Sep;50(3):447-452
pubmed: 28668689
Int J Infect Dis. 2017 Jul;60:57-60
pubmed: 28526565
J Bone Jt Infect. 2020 Oct 30;6(2):43-45
pubmed: 33178555

Auteurs

Javier Cobo (J)

Infectious Disease Department, Hospital Ramón y Cajal, IRYCIS, Ctra. Colmenar Viejo, 28034 Madrid, Spain.

Rosa Escudero-Sanchez (R)

Infectious Disease Department, Hospital Ramón y Cajal, IRYCIS, Ctra. Colmenar Viejo, 28034 Madrid, Spain.

Classifications MeSH